NURS FPX 4055 Assessment 4
[Student Name]
Capella University
[Prof. Name]
August 2025
NURS FPX 4055 Assessment 4: Health Promotion Plan Presentation
Greetings to all, and welcome to this seminar on health promotion. Teenagers and young adults in Schwenksville, Pennsylvania, between the ages of 11 and 26, are our target demographic in order to avoid HPV. An overview of HPV, its link to specific malignant illnesses, the benefits of early HPV vaccination, and how to effectively communicate the HPV vaccine to family members and healthcare providers will all be covered in this NURS FPX 4055 Assessment 4. To guarantee a generally targeted-outcome character, the session is guided by SMART goals that are in line with Healthy People 2030 objectives.
Presentation Overview
The health promotion plan presentation covers the basic information regarding HPV, including how it is spread and how it is linked to various malignancies. After that, we will talk about the effectiveness and safety of the HPV vaccine and encourage participants to think about getting it within the following 30 days. Gaining the confidence to discuss the vaccine with family members and medical professionals is another top objective. As stated in NURS FPX 4055 Assessment 4, interactive exercises will reinforce the material, and a post-presentation exam and survey will be used to gauge durability.
Key Facts About HPV and Cancer Risk
Health promotion plan example can be used to address HPV, a common virus that is mostly transmitted through sexual contact and skin-to-skin contact. Adolescents in Pennsylvania are still only 68.7% fully vaccinated against HPV, with the lowest rates occurring in the rural community of Schwenksville (48.7%) (PA.gov, 2025).
Cervical, oropharyngeal, anal, and vaginal cancers are among the many cancers that HPV is a major cause of. The body is unable to identify high-risk strains, such as HPV 16 and 18, which eventually causes cell abnormalities and cancer. While the majority of illnesses are thought to be curable without treatment, some still cause serious health problems, underscoring the need for health promotion ideas for communities. NURS FPX 4055 Assessment 4 emphasizes the need of vaccination and routine checkups as preventative measures.
Benefits of Timely HPV Vaccination
As stressed in the health promotion plan presentation, it is best to vaccinate against the HPV virus when the child is 11 or 12 years old, as this allows the immune system to develop robust and long-lasting protection prior to potential exposure. To prevent HPV-related infections, this timetable maximizes the usage of vaccines (Hoes et al., 2021). Timely vaccination can significantly reduce the incidence of penile, anal, and oropharyngeal cancers, as well as cervical cancer, one of the most prevalent diseases in women worldwide (Cheng et al., 2020). Additionally, the vaccine prevents genital warts, which removes stigma and emotional distress a crucial point made in NURS FPX 4055 Assessment 4. Additionally, early vaccination contributes to the development of herd immunity overall, which reduces virus transmission and safeguards susceptible individuals (Xu et al., 2024).
Communication Strategies for HPV Vaccination
“As models for health promotion plan example, the messaging surrounding HPV vaccination must be grounded in evidence and show respect for all individuals. Reliable sources, such as the CDC and WHO, should be used to communicate the facts
regarding vaccine safety and effectiveness. It is wise to start a conversation and pose thoughtful queries about the vaccine’s long-term advantages (Kassymbekova et al., 2023). It’s also critical to dispel myths, such as the one described in NURS FPX 4055 Assessment 4, which states that getting an HPV vaccination helps prevent illness rather than promote early sexual engagement.
SMART Goals for the Session
In this session, three SMART goals were employed.
- Knowledge: According to a post-session test, at least 90% of participants will be able to correctly identify three facts about HPV and its link to cancer.
- Commitment: The participant agrees to set up the initial HPV vaccination dosage within 30 days.
- Confidence: At least 85% of respondents report feeling more comfortable discussing immunization with family members and healthcare professionals.
To improve relationship building, the next sessions can incorporate role plays and family participation.
Evaluation of SMART Goal Outcomes
Two SMART objectives were accomplished. Since 92.5 percent of survey participants said they could name at least three accurate facts concerning HPV, the knowledge aim was satisfactorily met. Since 85% of participants found it easier to discuss the vaccine, the confidence measure was met. Only 75% of respondents said they would schedule the jab, which is little less than the 80% threshold. Reluctance to cope with vaccine myths is a significant factor in NURS FPX 4055 Assessment 4, as some participants expressed a desire to consult the family before making a decision.
Role-playing can be used to enhance communication skills during follow-up visits as part of family treatment.
Alignment With Healthy People 2030 Objectives
“This session will demonstrate health promotion ideas for communities and contribute to the Healthy People 2030 target of raising teenage HPV vaccination rates. The initiative promoted health prevention, raised awareness, and enhanced knowledge about immunizations. Even though vaccination commitment fell short of the goal, the progress indicates that the tactics are effective; yet, they still require more improvement to overcome hesitation. As stressed in NURS FPX 4055 Assessment 4, the use of myth-busting solutions, family-oriented discussions, and post-visit communication will also help to increase acceptance.
Conclusion
As covered in NURS FPX 4055 Assessment 4, this health promotion workshop was significant because it emphasized the value of early HPV vaccination in preventing cancer and safeguarding the lives of residents in the Schwenksville area. As stated in the health promotion plan presentation, the program demonstrated indications that need additional improvement, specifically vaccine commitment, despite its success in educating and boosting confidence. The development of a healthy generation of adolescents and young adults as well as the community’s progress toward the Healthy People 2030 goals can be aided by evidence-based practices and community involvement.
Summary Table
| Key Focus Area |
Details |
Impact/Outcome |
| HPV Facts & Risks |
Sexually transmitted infections like HPV are linked to genital, throat, anal, and cervical cancers. Vaccination rates are low in rural regions like Schwenksville (48.7%). |
Early identification and vaccination helped to prevent HPV and lower the incidence of cancer. |
| Vaccination Benefits |
Early vaccination (ages 11–12) results in a stronger immune response and protects genital warts and several types of cancer (Hoes et al., 2021; Cheng et al., 2020). |
reduces risk for individuals and society in favor of population health. |
| Communication & SMART Goals |
Informational facts, well-informed questions, and debunking myths (Kassymbekova et al., 2023). Gaining knowledge, dedication, and communication confidence were the goals. |
Goals for knowledge (92.5%) and confidence (85) were met; however, vaccine commitment (75%) fell short of expectations; improvement is anticipated in the future. |
References
Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391
Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059
Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age: What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17. https://doi.org/10.1177/17455065211028996
Kassymbekova, K., Abdukhakimova, A., Zhakipbekova, B., & Kurmangaliyev, A. (2023). Communication approaches in vaccination promotion. Health Promotion International, 38(1). https://doi.org/10.1093/heapro/daac112
U.S. Department of Health and Human Services. (n.d.). HPV vaccination: Healthy People 2030. https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/incr ease-hpv-vaccine-rates
Xu, Y., Liang, S., & Zhao, Q. (2024). Community herd immunity and HPV: Modeling impacts of adolescent vaccination. Public Health Reports, 139(2), 215–223. https://doi.org/10.1177/00333549231102378
